KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis-Reference-Cited by-同舟云学术

KRAS-mutation incidence and prognostic value are metastatic site-specific in lung adenocarcinoma: poor prognosis in patients with KRAS mutation and bone metastasis

Published:2017-01-04 Issue:1 Volume:7 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Lohinai Zoltan,Klikovits Thomas,Moldvay Judit,Ostoros Gyula,Raso Erzsebet,Timar Jozsef,Fabian Katalin,Kovalszky Ilona,Kenessey István,Aigner Clemens,Renyi-Vamos Ferenc,Klepetko Walter,Dome Balazs,Hegedus Balazs

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep39721.pdf

Reference51 articles.

1. Bos, J. L. Ras Oncogenes in Human Cancer - a Review. Cancer Res 49, 4682–4689 (1989).

2. Prior, I. A., Lewis, P. D. & Mattos, C. A comprehensive survey of Ras mutations in cancer. Cancer Res 72, 2457–2467 (2012).

3. Aviel-Ronen, S., Blackhall, F. H., Shepherd, F. A. & Tsao, M. S. K-ras mutations in non-small-cell lung carcinoma: A review. Clin Lung Cancer 8, 30–38 (2006).

4. Lohinai, Z. et al. Distinct Epidemiology and Clinical Consequence of Classic Versus Rare EGFR Mutations in Lung Adenocarcinoma. Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer 10, 738–746 (2015).

5. Cserepes, M. et al. Subtype-specific KRAS mutations in advanced lung adenocarcinoma: A retrospective study of patients treated with platinum-based chemotherapy. European journal of cancer 50, 1819–1828 (2014).

Cited by 60 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The HOXC10/NOD1/ERK axis drives osteolytic bone metastasis of pan-KRAS-mutant lung cancer;Bone Research;2024-08-27

2. A Review of the Molecular Determinants of Therapeutic Response in Non-Small Cell Lung Cancer Brain Metastases;International Journal of Molecular Sciences;2024-06-26

3. KRASG12C mutant lung adenocarcinoma: unique biology, novel therapies and new challenges;Pathology and Oncology Research;2024-01-04

4. Bone metastasis in non-small-cell lung cancer: genomic characterization and exploration of potential targets;Therapeutic Advances in Medical Oncology;2024-01

5. Synergistic effect of Dactolisib/Lys05 combination on autophagy in A549 cells;Acta Biochimica Polonica;2023-09-07